Intellectual Property India Publishes Patent Application for 'Oncolytic Virus And Uses Thereof' Filed by Janssen Biotech, Inc.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065567 A) filed by Janssen Biotech, Inc., Horsham, U.S.A., on July 9, for 'oncolytic virus and uses thereof.'

Inventor(s) include Baillat, David; Drake, Charles; Fuhrmann, Steven R.; Harvilla, Paul; Laquerre, Sylvie; Mulvey, Matthew; Sepulveda, Manuel; Shamanna, Raghavendra; Tamot, Ninkka; Taylor, Kathryne; and Yamada, Douglas.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are oncolytic viruses including payload genes, encompassing genes that encode IL-12, FLT3L, CD40 agonists, and/or CTLA-4 antibodies. Also provided are ...